Study protocol for developing a patient-reported outcome measure for infection screening in hematological patients with secondary immunodeficiency
Abstract Background Patients with chronic lymphocytic leukemia (CLL) or multiple myeloma (MM) frequently develop secondary immunodeficiencies (SID), on the basis of both their respective disease, as well as immunosuppressive therapies, leading to increased infection risks and impaired health-related...
Zapisane w:
| Główni autorzy: | , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
BMC
2025-10-01
|
| Seria: | BMC Cancer |
| Hasła przedmiotowe: | |
| Dostęp online: | https://doi.org/10.1186/s12885-025-14996-y |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
